Position in JANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$973,132
-$1,379,547 QoQ
Shares Held
63,355
-62.8% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 198 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. JANX ranks #112 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 7 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 |
All Filings in JANX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $973,132 | 63,355 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $2,352,679 | 170,484 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $323,023 | 13,217 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,221,619 | 96,174 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,562,244 | 168,972 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,526,037 | 65,858 | Shares | Sole | 2025-02-12 | |
| 2023-09-30 | $118,671 | 11,773 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||